This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
Joe McKamey, general manager at Marcrom’s Pharmacy, highlights the potential pitfalls or misconceptions that pharmacies may encounter when opening a Medicare-focused insurance agency.
Joe McKamey, general manager at Marcrom’s Pharmacy in Manchester, Tennessee, talks about why pharmacies should open their own Medicare-focused insurance agency and what steps and preparations they can take to ensure a successful launch and operation.
A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.
The Patient Experience Survey (PES) series continues to reveal how health insurance is not working as it should for too many Americans — especially vulnerable groups.
Innovation in the vaccine area continues. In 2023, the FDA approved six vaccines, including several important firsts. But they face a difficult landscape where federal policies dictate coverage.
Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.
Insurers and pharmacy benefit managers (PBMs) continue to shift more and more costs to patients. For seniors who rely on Medicare Part D, the out-of-pocket costs for medicines can sometimes be a barrier. And a new analysis from the Medicare Payment Advisory Commission (MedPAC) shows why this is a problem that must be addressed.
A survey of more than 5,000 Americans conducted with Ipsos found that 30% of insured Americans say they face a financial barrier to care, such as unaffordable out-of-pocket costs or a lack of savings to pay for emergency or unforeseen expenses.
The National Rosacea Society found that a lack of health insurance or the high cost of a copay caused 52% of respondents to avoid obtaining medical care for their rosacea.
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program.
A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on Wednesday, but some Wall Street analysts believe the legislation is unlikely to gain much traction, at least for now.
Social determinants of health (SDOH), such as financial disparities or lack of insurance, create barriers to accessing breakthrough therapies like BTK inhibitors among patients with CLL and SLL.
Pharmaceutical’s weight loss pill described as ‘underwhelming’, also piling pressure on share price AstraZeneca shares tumbled on Tuesday wiping £14bn off the value of Britain’s biggest drug maker, after a report that dozens of senior executives at its China unit could be implicated in an insurance fraud case in the country’s pharmaceutical sector.
Bonjesta costs about $490 without insurance for 30, 20-20 mg extended- release tablets. How much does Bonjesta cost without insurance? The copays for Bonjesta, with insurance and Medicare, vary by plan. Drug costs may be affected by differences in insurance plans and specific drug formularies. RELATED: What is Bonjesta ?
For a decade and a half, Americans have been guaranteed that no matter their health insurer, certain preventive care like cancer screenings are free of charge. That’s because an Affordable Care Act provision has required insurers to fully cover services given an A or B recommendation by an expert task force.
A recent study found that Infants younger than 3 months, those born prematurely, and those who were publicly insured were at a higher risk for intubation.
Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.
Without insurance, the average retail price of Actos is $2,111 for 90, 30 mg tablets. How much does Actos (pioglitazone) cost without insurance? Without insurance, the price of Actos can vary depending on the quantity, dosage, and pharmacy you purchase the drug from. Without insurance, Actos costs $2,111 for 90, 30 mg tablets.
A new CDC report on data collected by the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy, indicates that medication for opioid use disorder is more often given to individuals who are White, older, and have private insurance.
Insurers like UnitedHealth are profiting off of the Medicare Advantage system, and it’s causing problems for both doctors and patients. Traditional Medicare is run by the federal government, while Medicare Advantage health insurance plans are operated by private companies like UnitedHealth. Read the rest…
Without insurance, Depakote costs $769 for 90, 500 mg delayed-release tablets. How much does Depakote cost without insurance? Without insurance, the price of Depakote may vary depending on certain factors. Without insurance, the price of Depakote may vary depending on certain factors. RELATED: What is Depakote?
There is only one place in the health care system where middlemen refuse to share negotiated prices with patients, and that’s at the pharmacy counter. A new report reveals how this harmful tactic leads to higher costs for patients.
Brian Rakers, senior vice president of distribution and member support at Pharmacists Mutual Insurance Group, talked cybersecurity during a session at AAP 2024.
would force the companies that own health insurers or PBMs to divest their pharmacy businesses within three years. Federal Trade Commission , The Wall Street Journal reports. A Senate bill, sponsored by Sens. Elizabeth Elizabeth Warren (D-Mass.) and Josh Hawley (R-Mo.),
Plus, we’ve got tips on how to save, even if you don’t have insurance. How much does Combivent Respimat cost without insurance? For people who don’t have insurance or Medicare—or whose plans don’t cover Combivent Respimat—the average retail price is $636 for a 4 gm of 20–100 mcg/act inhaler with 120 inhalations. Many times, yes.
The Biden administration on Monday announced it would finalize a highly anticipated proposal meant to force health insurers to cover mental health care on the same basis as physical health conditions.
For the moment, the state has not fined the company, although it may yet do so, according to a consent order. A department spokesperson declined to comment.
How much does Cequa cost without insurance? The exact cost of Cequa without health insurance will vary, depending on which pharmacy is used. The listed price without insurance references the price of brand-name drugs (unless otherwise specified). Paying that amount monthly can be daunting. Related: What is Cequa?
Like many Americans, Holden Karau said she was fed up with health insurance. The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk.
How much does Plenvu cost without insurance? Is Plenvu covered by insurance? The average copay for Plenvu may vary depending on what type of insurance plan you have and your level of coverage. The best way to find out is to call your insurance company and ask whether it is covered under your plan.
Without insurance, the average retail price for two FreeStyle Libre 3 Plus sensors, a 28-day supply, is $232. The price without insurance adds up to just over $3,000 for one year. Is FreeStyle Libre 3 covered by insurance? Insurance plans are different and may or may not cover the FreeStyle Libre 3 Plus sensor.
To further understand PBM market concentration, researchers separately analyzed commercial insurance, Medicare Part D, and Medicaid managed care market strategies of the 3 biggest PBMs.
Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI. Continue to STAT+ to read the full story…
Health insurance companies will still offer older adults a lot of plan choices with low, or completely free, premiums. However, insurers have made important but subtle tweaks to next year’s plans that will force millions of members to shell out more for their prescription drugs and overall medical care than they do currently.
For years, health insurers battled to gain market share in the lucrative privatized Medicare program. When insurers release their 2025 plan offerings on Oct. Now, the opposite is true. Some of the companies say they designed their 2025 plans with an eye toward ditching members. 1, there likely will be fewer choices and freebies.
Insurer-imposed barriers like high deductibles and coinsurance shift the cost of life-saving care onto patients. Manufacturers and others have stepped forward to assist patients who face high out-of-pocket costs, using programs like copay coupons to help eligible, commercially insured patients afford their out-of-pocket costs.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content